|
Q4 2019
Filed on Jan 29, 2020
|
1,929,093
|
$7.08 - $11.08
$13.7M - $21.4M
|
|
|
Q4 2019
Filed on Jan 29, 2020
|
19,996
|
$136.92 - $154.3
$2.74M - $3.09M
|
|
|
Q4 2019
Filed on Jan 29, 2020
|
293,975
|
N/A
|
|
|
Q4 2019
Filed on Jan 29, 2020
|
4,680
|
$45.02 - $74.18
$211K - $347K
|
|
|
Q4 2019
Filed on Jan 29, 2020
|
174,597
|
$7.03 - $10.08
$1.23M - $1.76M
|
|
|
Q4 2019
Filed on Jan 29, 2020
|
65,398
|
$5.23 - $8.3
$342K - $543K
|
|
|
Q4 2019
Filed on Jan 29, 2020
|
23,093
|
$52.35 - $63.15
$1.21M - $1.46M
|
|
|
Q4 2019
Filed on Jan 29, 2020
|
275,199
|
$41.54 - $51.9
$11.4M - $14.3M
|
|
|
Q4 2019
Filed on Jan 29, 2020
|
67,765
|
$12.31 - $26.33
$834K - $1.78M
|
|
|
Q4 2019
Filed on Jan 29, 2020
|
190,515
|
N/A
|
|
|
Q3 2019
Filed on Oct 30, 2019
|
97,551
|
$8.38 - $13.14
$817K - $1.28M
|
|
|
Q3 2019
Filed on Oct 30, 2019
|
511,579
|
$0.79 - $2.47
$404K - $1.26M
|
|
|
Q3 2019
Filed on Oct 30, 2019
|
185,100
|
$44.13 - $55.88
$8.17M - $10.3M
|
|
|
Q3 2019
Filed on Oct 30, 2019
|
127,639
|
$6.46 - $10.04
$825K - $1.28M
|
|
|
Q3 2019
Filed on Oct 30, 2019
|
208,053
|
$3.93 - $15.35
$818K - $3.19M
|
|
|
Q3 2019
Filed on Oct 30, 2019
|
15,276
|
$35.12 - $41.92
$536K - $640K
|
|
|
Q3 2019
Filed on Oct 30, 2019
|
895,366
|
$13.03 - $17.9
$11.7M - $16M
|
|
|
Q3 2019
Filed on Oct 30, 2019
|
541,076
|
$13.56 - $21.01
$7.34M - $11.4M
|
|
|
Q3 2019
Filed on Oct 30, 2019
|
146,073
|
$40.61 - $53.28
$5.93M - $7.78M
|
|
|
Q3 2019
Filed on Oct 30, 2019
|
5,606
|
N/A
|
|
|
Q3 2019
Filed on Oct 30, 2019
|
297,649
|
$25.23 - $50.69
$7.51M - $15.1M
|
|
|
Q3 2019
Filed on Oct 30, 2019
|
72,417
|
$154.21 - $257.38
$11.2M - $18.6M
|
|
|
Q3 2019
Filed on Oct 30, 2019
|
915,034
|
N/A
|
|
|
Q3 2019
Filed on Oct 30, 2019
|
210,194
|
$31.22 - $42.91
$6.56M - $9.02M
|
|
|
Q3 2019
Filed on Oct 30, 2019
|
15,611
|
$129.81 - $149.29
$2.03M - $2.33M
|
|
|
Q3 2019
Filed on Oct 30, 2019
|
511,633
|
N/A
|
|
|
Q3 2019
Filed on Oct 30, 2019
|
297,494
|
$25.79 - $34.62
$7.67M - $10.3M
|
|
|
Q3 2019
Filed on Oct 30, 2019
|
314,592
|
$3.29 - $4.35
$1.04M - $1.37M
|
|
|
Q3 2019
Filed on Oct 30, 2019
|
53,531
|
$77.55 - $95.02
$4.15M - $5.09M
|
|
|
Q3 2019
Filed on Oct 30, 2019
|
70,799
|
$8.31 - $21.17
$588K - $1.5M
|
|
|
Q3 2019
Filed on Oct 30, 2019
|
134,926
|
$9.81 - $14.94
$1.32M - $2.02M
|
|
|
Q3 2019
Filed on Oct 30, 2019
|
128,449
|
$7.42 - $13.0
$953K - $1.67M
|
|
|
Q2 2019
Filed on Aug 01, 2019
|
92,005
|
N/A
|
|
|
Q2 2019
Filed on Aug 01, 2019
|
207,406
|
$61.47 - $71.7
$12.7M - $14.9M
|
|
|
Q2 2019
Filed on Aug 01, 2019
|
43,614
|
$32.22 - $45.0
$1.41M - $1.96M
|
|
|
Q2 2019
Filed on Aug 01, 2019
|
17,520
|
$47.64 - $74.87
$835K - $1.31M
|
|
|
Q2 2019
Filed on Aug 01, 2019
|
105,871
|
N/A
|
|
|
Q2 2019
Filed on Aug 01, 2019
|
20,409
|
$44.71 - $50.48
$912K - $1.03M
|
|
|
Q2 2019
Filed on Aug 01, 2019
|
119,166
|
$7.71 - $14.54
$919K - $1.73M
|
|
|
Q2 2019
Filed on Aug 01, 2019
|
379,815
|
$36.25 - $43.74
$13.8M - $16.6M
|
|
|
Q2 2019
Filed on Aug 01, 2019
|
120,400
|
N/A
|
|
|
Q2 2019
Filed on Aug 01, 2019
|
233,058
|
N/A
|
|
|
Q2 2019
Filed on Aug 01, 2019
|
74,524
|
N/A
|
|
|
Q2 2019
Filed on Aug 01, 2019
|
68,223
|
$24.79 - $32.96
$1.69M - $2.25M
|
|
|
Q2 2019
Filed on Aug 01, 2019
|
6,950
|
$111.96 - $142.02
$778K - $987K
|
|
Adamas Pharmaceuticals Inc
|
Q2 2019
Filed on Aug 01, 2019
|
82,413
|
N/A
|
|
|
Q2 2019
Filed on Aug 01, 2019
|
29,370
|
N/A
|
|
|
Q2 2019
Filed on Aug 01, 2019
|
302,337
|
$9.61 - $13.17
$2.91M - $3.98M
|
|
|
Q2 2019
Filed on Aug 01, 2019
|
23,906
|
$64.14 - $76.89
$1.53M - $1.84M
|
|
|
Q2 2019
Filed on Aug 01, 2019
|
78,681
|
$68.8 - $84.28
$5.41M - $6.63M
|
|